OrthoPediatrics Corp.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US68752L1008
USD
18.17
0.47 (2.66%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
MiMedx Group, Inc.
Varex Imaging Corp.
Stevanato Group SpA
SI-BONE, Inc.
Paragon 28, Inc.
Treace Medical Concepts, Inc.
Avanos Medical, Inc.
Embecta Corp.
OrthoPediatrics Corp.
The Beauty Health Co.
Quanterix Corp.
Why is OrthoPediatrics Corp. ?
1
Flat results in Jun 25
  • INTEREST(HY) At USD 2.24 MM has Grown at 149.67%
  • NET PROFIT(9M) At USD -25.34 MM has Grown at -23.43%
  • ROCE(HY) Lowest at -11.49%
2
Risky - Negative EBITDA
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -28.26%, its profits have fallen by -37%
3
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -28.26% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is OrthoPediatrics Corp. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
OrthoPediatrics Corp.
-30.6%
-0.76
47.24%
S&P 500
13.22%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
25.95%
EBIT Growth (5y)
-156.54%
EBIT to Interest (avg)
-12.75
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.05
Sales to Capital Employed (avg)
0.42
Tax Ratio
3.28%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
77.38%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.51
EV to EBIT
-17.60
EV to EBITDA
-46.49
EV to Capital Employed
1.49
EV to Sales
2.55
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-8.46%
ROE (Latest)
-9.19%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company
INVENTORY TURNOVER RATIO(HY)

Highest at 0.68 times

NET SALES(Q)

Highest at USD 61.08 MM

PRE-TAX PROFIT(Q)

Highest at USD -4.09 MM

NET PROFIT(Q)

Highest at USD -4.14 MM

-16What is not working for the Company
INTEREST(HY)

At USD 2.24 MM has Grown at 149.67%

NET PROFIT(9M)

At USD -25.34 MM has Grown at -23.43%

ROCE(HY)

Lowest at -11.49%

DEBT-EQUITY RATIO (HY)

Highest at 7.26 %

RAW MATERIAL COST(Y)

Grown by 6.87% (YoY

DEBTORS TURNOVER RATIO(HY)

Lowest at 4.61 times

Here's what is working for OrthoPediatrics Corp.
Net Sales
Highest at USD 61.08 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Pre-Tax Profit
Highest at USD -4.09 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Pre-Tax Profit
At USD -4.09 MM has Grown at 50.83%
over average net sales of the previous four periods of USD -8.32 MM
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit
Highest at USD -4.14 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

Net Profit
At USD -4.14 MM has Grown at 48.09%
over average net sales of the previous four periods of USD -7.98 MM
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

Inventory Turnover Ratio
Highest at 0.68 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Here's what is not working for OrthoPediatrics Corp.
Interest
At USD 2.24 MM has Grown at 149.67%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Debt-Equity Ratio
Highest at 7.26 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio
Lowest at 4.61 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost
Grown by 6.87% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales